Lapatinib Ditosylate Monohydrate CAS 388082-78-8 Maʻemaʻe >99.0% (HPLC)

ʻO ka wehewehe pōkole:

Inoa Kemika: Lapatinib Ditosylate Monohydrate

CAS: 388082-78-8

Maʻemaʻe: >99.0% (HPLC)

ʻAno: Melemele ʻeleʻele a i ka pauka Crystalline Melemele

Hoʻokaʻaʻike: Kauka Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

Lapatinib Intermediates:

Lapatinib Base	CAS 231277-92-2
ʻO Lapatinib Ditosylate Monohydrate	CAS 388082-78-8
Sodium Methanesulfinate	CAS 20277-69-4
3-Chloro-4-(3-Fluorobenzyloxy)aniline	CAS 202197-26-0
2-Aminoethyl Methyl Sulfone Hydrochloride	CAS 104458-24-4
4-Chloro-6-Iodoquinazoline	CAS 98556-31-1
6-Iodo-4-Hydroxyquinazoline	CAS 16064-08-7
5-Formyl-2-Furanboronic Acid	CAS 27329-70-0
5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde	CAS 231278-84-5

Na Waiwai Kemika:

Inoa Kimia	ʻO Lapatinib Ditosylate Monohydrate
Nā huaʻōlelo like	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
Helu CAS	388082-78-8
Kūlana Kūʻai	Loaʻa
ʻĀpana Molekala	C29H26ClFN4O4S·2(C7H8O3S)·H2O
Kaumaha Molecular	943.48
COA & MSDS	Loaʻa
Ke kumu	Shanghai, Kina
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Melemele a i ka pauda kristal melemele
Maʻemaʻe / Kaʻina Hanana	≥99.0% (HPLC)
Lae hehee	240.0~242.0 ℃
Māmā (KF)	1.9-2.4%
Hoʻokahi haumia	≤0.50%
Huina paumaele	≤1.00%
Nā Metala Kaumaha (e like me Pb)	≤20ppm
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	API;No ka mālama ʻana i nā poʻe maʻi me ka maʻi maʻi umauma

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

FAQ:

388082-78-8 - Noi:

ʻO Lapatinib Ditosylate Monohydrate (CAS: 388082-78-8) ka paʻakai ditosylate oCAS 231277-92-2, he quinazoline synthetic, hoʻoikaika waha me ka hana antineoplastic.Hoʻololi ia i ka phosphorylation o ka epidermal growth factor receptor (EGFR), ErbB2, a me ka Erk-1 a me-2 a me AKT kinases;ʻAʻole hoʻi ia e kāohi i nā pae protein cyclin D i nā laina cell tumor a me nā xenografts.Ua hoʻopili ʻia ʻo EGFR a me ErbB2 i ka ulu ʻana o nā ʻano tumora like ʻole.Ua hoʻokuʻu ʻia no ka mālama ʻana i ka maʻi maʻi umauma HER2 (ErbB2) kiʻekiʻe a i ʻole metastatic i nā wahine i loaʻa i ka lāʻau lapaʻau mua.Ua ʻike ʻia ka lāʻau lapaʻau e GlaxoSmithKline.